Brief: Enorama Pharma Appoints Claes Eliasson As Interim CFO
Feb 25 (Reuters) - Enorama Pharma AB ERMA.ST :
* APPOINTS CLAES ELIASSON AS INTERIM CFO
* CLAES ELIASSON ASSUMES ROLE OF INTERIM CFO IMMEDIATELY
Source text: ID:nWkr6jW329
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO